| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/27/2003 | US20030040097 Nucleotide sequences coding polypeptides for use in the diagnosis and treatment of liver, immunological, kidney, cancer and cell proliferative disorders |
| 02/27/2003 | US20030040096 Nucleotide sequences coding enzmatic polypeptide for use in the treatment of acquired immunodeficiency syndromes, nervous system and ischemic injury disorders |
| 02/27/2003 | US20030040095 Generation of preferential protein for use in the trement of thrombosis and heart defscts; obtain cells, transform with vector containing preferential protein, recover transformed cells, propagate, recover protein |
| 02/27/2003 | US20030040093 Platelet activating factor acetylhydrolase, and gene thereof |
| 02/27/2003 | US20030040091 Mutant 1,3-propanediol dehydrogenase |
| 02/27/2003 | US20030040089 Protein complex for use in the diagnosis, treatment and prevention of metabolic disorders |
| 02/27/2003 | US20030040086 Generation of ascorbic acid intermediate in recombinant cell; obtain cells, transform with vector containg polypeptides, recover transformed cells, propagate, expression vector, recover polypeptide |
| 02/27/2003 | US20030040084 Macrolide analogs |
| 02/27/2003 | US20030040083 Dual specificity antibodies and methods of making and using |
| 02/27/2003 | US20030040082 Mutant pro-neurotrophin with improved activity |
| 02/27/2003 | US20030040078 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of cell proliferative and tumor disorders |
| 02/27/2003 | US20030040076 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/27/2003 | US20030040071 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of cell proliferative and tumor disorders |
| 02/27/2003 | US20030040052 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of human cancers |
| 02/27/2003 | US20030040050 Nucleotide sequences coding polypeptide for use in the treatment of inflammatory disorders |
| 02/27/2003 | US20030040048 Nucleotide sequences coding polypeptide for use in the treatment of cancer, heart and viral diseases |
| 02/27/2003 | US20030040047 Generation of preferential protein in cells.; obtain cells, transform with vector, exoress vector, recover protein |
| 02/27/2003 | US20030040046 Netrin receptors |
| 02/27/2003 | US20030040045 Mammalian sweet taste receptors |
| 02/27/2003 | US20030040044 Anti-dual integrin antibodies, compositions, methods and uses |
| 02/27/2003 | US20030040042 Nucleotide sequences coding growth factor for use as wound healing and tissue repair agent |
| 02/27/2003 | US20030040040 Dna molecules for expression of bile salt-stimulated lipase |
| 02/27/2003 | US20030040039 Nucleotide sequences coding polypeptide for use in the treatment of diabetes |
| 02/27/2003 | US20030040038 Screening effect of modulators on target cells; obtain cell, transform with expresion vector coding activator and preferential protein, monitor cell activity, compare to control |
| 02/27/2003 | US20030040037 In vitro modification of glycosylation patterns of recombinant glycopeptides |
| 02/27/2003 | US20030040022 Dopamine receptors and genes |
| 02/27/2003 | US20030040019 Biological material chip |
| 02/27/2003 | US20030040015 Detection of moduators of enzyme activity; obtain sample containing oxidoreductase, incubate with modulator, monitor adjustment in enzyme activity |
| 02/27/2003 | US20030040012 Method of detecting protein-protein interaction |
| 02/27/2003 | US20030040007 Human BMP-7 promoter and method for exploring bone-related substance by using the same |
| 02/27/2003 | US20030040006 Methods and kits for obtaining DNA end sequence information for large cloned inserts and uses thereof |
| 02/27/2003 | US20030040005 Detection of prostate cancer in humans; obtain tissue sample, extract nucleotide sequences, incubate with probe, detect signal from probe, presence of signal indicates cancer |
| 02/27/2003 | US20030040003 Detection of mutation in preferential nucleotide sequences; obtain cells, fuse, recover hybrids, monitor gene activity in hybrids, detect aberrant gene activity |
| 02/27/2003 | US20030040000 Methods for attaching nucleic acid molecules to electrically conductive surfaces |
| 02/27/2003 | US20030039999 B7 related protein-2 molecules and uses thereof |
| 02/27/2003 | US20030039995 YS68 gene involved in primitive hematopoiesis |
| 02/27/2003 | US20030039990 Expression vector for use as gene transfer tool ingenetic engineering |
| 02/27/2003 | US20030039989 Method for constructing an expression library and uses thereof |
| 02/27/2003 | US20030039988 Nucleotide sequences for use as tools in genetic engineering |
| 02/27/2003 | US20030039987 Defects in periaxin associated with myelinopathies |
| 02/27/2003 | US20030039984 Sequences upstream of the CARP gene, vectors containing them and uses thereof |
| 02/27/2003 | US20030039983 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cancer |
| 02/27/2003 | US20030039982 Nucleotide sequences coding polypeptide for use in the diagnosis treatment and prevention of tumors |
| 02/27/2003 | US20030039970 Diagnosing cancer in humans; obtain tissue sample, determine concentration of calreticulin in sample, compare to control, evaluate for cancer |
| 02/27/2003 | US20030039966 Genetic engineering; bone disorders |
| 02/27/2003 | US20030039965 Algorithmic determination of flanking DNA sequences that control the expression of sets of genes in prokaryotic, archea and eukaryotic genomes |
| 02/27/2003 | US20030039962 Therapy, medical diagnosis, drug |
| 02/27/2003 | US20030039961 Nucleic acid sequence detection employing amplification probes |
| 02/27/2003 | US20030039960 Transferring therapeutic agent into body cavity of mammal; prepare therapeutic agent, obtain mammal, inject mammal, monitor mamamlian response to therapeutic agent |
| 02/27/2003 | US20030039958 Screening polypeptides pool to detect preferential polypeptide activity; immobilize target nucleotide sequences on microarray, express nucleotide sequences, recover protein, interact with preferential polypeptide, monitor activity |
| 02/27/2003 | US20030039957 Functional protein expression for rapid cell-free phenotyping |
| 02/27/2003 | US20030039955 Compositions and methods for production of RNA viruses and RNA virus-based vector particles |
| 02/27/2003 | US20030039954 Viral nucleotide sequences for use in the diagnosis, prevention and treatment of viral diseases |
| 02/27/2003 | US20030039664 Isolated nucleotide sequences associated with multiple sclerosis or rheumatoid arthritis and a process of detecting |
| 02/27/2003 | US20030039663 Vaccine; neutralizing antibodies; detecting infections |
| 02/27/2003 | US20030039660 Recombinant hybrid allergen constructs with reduced allergenicity that retain immunogenicity of the natural allergen |
| 02/27/2003 | US20030039659 Self antigen vaccines for treating B cell lymphomas and other cancers |
| 02/27/2003 | US20030039656 Modified reoviral therapy |
| 02/27/2003 | US20030039655 Novel engineered superantigen for human therapy |
| 02/27/2003 | US20030039654 Amino acid sequence of parathyroid hormone/parathyroid hormone related protein modulating domains and a vehicle for to stimulate renal calcium reabsorption |
| 02/27/2003 | US20030039649 Selecting variable region framework sequences from human antibody genes by comparing canonical CDR structure types for corresponding CDRs from a library of human germline antibody sequences |
| 02/27/2003 | US20030039647 Tetraspan protein and uses thereof |
| 02/27/2003 | US20030039646 Receptor interacting protein, which binds to itself and to other intracellular modulatory proteins; treating tumor cells or HIV-infected cells |
| 02/27/2003 | US20030039643 Investigation, diagnosis and treatment of subjects suspected of or suffering from alpha-N- acetylglucosaminidase deficiency |
| 02/27/2003 | US20030039641 Cells expressing anti-fc receptor binding components |
| 02/27/2003 | US20030039640 Infecting cells with a retrovirus in the presence of an immobilized material including a ligand which bings to the cell and a ligand which binds to the retrovirus |
| 02/27/2003 | US20030039639 Isolated stromal cells for use in the treatment of diseases of the central nervous system |
| 02/27/2003 | US20030039638 Administering to a donor a pharmaceutical composition containing carbon monoxide, obtaining an organ, tissue or cell and transplanting to a recipient |
| 02/27/2003 | US20030039636 Novel self-inactivating (SIN) lentiviral vectors |
| 02/27/2003 | US20030039634 Recombinant adenoviruses, use thereof for preparing AAVS, complementary cell line, and pharmaceutical compositions containing said adenoviruses |
| 02/27/2003 | US20030039633 A replication-competent adenovirus vector comprising an adenovirus gene essential for replication; use as antitumor agent |
| 02/27/2003 | US20030039632 Novel bacteriocins, transport and vector system and method of use thereof |
| 02/27/2003 | US20030039631 Adenovirus p53 compositions and methods |
| 02/27/2003 | US20030039629 Espression enhancer for protein synthesis inhibitory genes |
| 02/27/2003 | US20030038828 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/27/2003 | US20030038827 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/27/2003 | US20030038826 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/27/2003 | US20030038071 System and method for manipulating magnetically responsive particles in fluid samples to collect DNA or RNA from a sample |
| 02/27/2003 | US20030038043 Card-shaped storage case for articles of daily use and/or consumer articles |
| 02/27/2003 | CA2496542A1 Humanised baculovirus |
| 02/27/2003 | CA2484062A1 Dna purification and recovery from high particulate and solids samples |
| 02/27/2003 | CA2459450A1 Yeast arrays, methods of making such arrays, and methods of analyzing such arrays |
| 02/27/2003 | CA2458890A1 Recombinant anti-plasmodium falciparum antibodies |
| 02/27/2003 | CA2458648A1 Secreted proteins |
| 02/27/2003 | CA2458643A1 Nucleic-acid associated proteins |
| 02/27/2003 | CA2458625A1 Transporters and ion channels |
| 02/27/2003 | CA2458193A1 Development of transgenic model for interventions in neurodegenerative diseases |
| 02/27/2003 | CA2457932A1 Sodium channel regulators and modulators |
| 02/27/2003 | CA2457850A1 Novel amylases and uses thereof |
| 02/27/2003 | CA2457805A1 Bovine leptin protein, antisense and antibody |
| 02/27/2003 | CA2457789A1 Conformation-activity relationship of apoptosis-inducing phosphodiester oligonucleotides |
| 02/27/2003 | CA2457787A1 Use of associations between at least one nucleic sequence polymorphism of the sh2 gene and at least one seed quality characteristic in plant selection methods |
| 02/27/2003 | CA2457783A1 Oligonucleotide compositions and their use to induce apoptosis |
| 02/27/2003 | CA2457781A1 Kgf polypeptide compositions |
| 02/27/2003 | CA2457730A1 Solid compositions for selective adsorption from complex mixtures |
| 02/27/2003 | CA2457611A1 Novel molecular target for neurotoxicity |
| 02/27/2003 | CA2457370A1 Age-associated markers |
| 02/27/2003 | CA2457365A1 Polymorphisms associated with ion-channel disease |
| 02/27/2003 | CA2457321A1 Combinatorial methods for inducing cancer cell death |
| 02/27/2003 | CA2457318A1 Molecular interaction sites of rnase prna and methods of modulating the same |